v3.22.2.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 5,051 $ 8,413
Trade accounts receivable, net of allowance for doubtful accounts of $XX and $346, respectively 26,876 20,232
Inventories, net 40,769 33,189
Prepaid expenses and other current assets 6,241 4,690
Total current assets 78,937 66,524
Property, plant and equipment, net 21,898 23,205
Goodwill 37,066 38,068
Other intangible assets, net 16,095 17,390
Deferred income taxes, net 11,963 11,472
Other noncurrent assets 1,981 2,879
Total assets 167,940 159,538
Current liabilities:    
Accounts payable 15,827 9,823
Current portion of long-term debt 2,000 2,000
Accrued compensation and related benefits 2,000 1,842
Accrued expenses and other current liabilities 8,254 5,259
Total current liabilities 28,081 18,924
Long-term debt, net 20,874 18,857
Deferred income taxes 1,996 2,254
Other noncurrent liabilities 1,673 1,760
Total liabilities 52,624 41,795
Commitments and contingencies
Stockholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,568,210 shares at September 30, 2022 and 20,522,427 shares at December 31, 2021; outstanding – 16,133,618 shares at September 30, 2022 and 16,089,832 shares at December 31, 2021 2,057 2,052
Capital in excess of par value 187,181 186,518
Accumulated deficit (47,727) (47,832)
Accumulated other comprehensive loss (4,842) (1,653)
Treasury stock - at cost; 4,434,592 shares at September 30, 2022 and 4,432,595 shares at December 31, 2021 21,480 21,469
Total Ultralife Corporation equity 115,189 117,616
Non-controlling interest 127 127
Total stockholders’ equity 115,316 117,743
Total liabilities and stockholders’ equity $ 167,940 $ 159,538